Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Neurological and cognitive problems news

Show

From To
Marijuana may help HIV patients keep mental stamina longer

A chemical found in marijuana, known as tetrahydrocannabinol, or THC, has been found to potentially slow the process in which mental decline can occur in up to 50 percent of HIV patients, says a new Michigan State University study.

Published
07 February 2018
From
Michigan State University
HIV does not increase aging-related brain changes in patients on ART

Researchers said they found no evidence that HIV accelerates aging-related brain changes over a 2-year period in middle-aged patients on successful ART.

Published
16 January 2018
From
Healio
Middle-aged HIV-positive people have increased risk of 'silent' cerebral vascular disease linked to more severe health problems

Prevalence of silent cerebral small-vessel disease (CSVD) – an important precursor to more serious neurocognitive conditions – is significantly higher among middle-aged HIV-positive people compared

Published
02 January 2018
By
Michael Carter
No change in cognitive function or brain structure in people taking effective HIV treatment for 2 years

People with HIV taking antiretroviral treatment who had undetectable viral load did not suffer any loss of cognitive function or brain volume during a two-year

Published
13 November 2017
By
Keith Alcorn
Cognitive Impairment Risk Rises With Increasing Age of People With HIV

Researchers identified this advancing risk after controlling for expected cognitive decline based on age.

Published
20 October 2017
From
Poz
Chronic pain common in people living with HIV

HIVMA comprehensive guidelines recommend screening everyone with HIV, offering multidisciplinary treatment focusing on non-drug options.

Published
14 September 2017
From
EurekAlert
Case reports of severe dolutegravir-related depression

Severe depression can be a side-effect of treatment with the anti-HIV drug dolutegravir. In HIV Medicine, clinicians from the Netherlands report two cases of rapid onset of

Published
05 September 2017
By
Michael Carter
Few people with HIV starting raltegravir and dolutegravir change therapy because of side-effects

Only a few people starting an integrase inhibitor discontinue the treatment during the first year of therapy due to drug-related toxicities, investigators from Switzerland report in an advance

Published
21 July 2017
By
Michael Carter
People treated with atazanavir had lower risk of stroke and heart attack

People who started HIV treatment with a drug combination containing atazanavir (Reyataz) were significantly less likely to suffer a heart attack or stroke than people

Published
18 July 2017
By
Keith Alcorn
Is there HIV in my brain? Neurologist Dr. Joanna Hellmuth fills us in

Twice a month, the San Francisco AIDS Foundation program Positive Force hosts free The Dr. Is In events for people living with HIV in our community. This month, we invited Joanna Hellmuth, MD, MHS, a neurologist at the University of California, San Francisco, to share information about age- and HIV-related changes to thinking, memory and other cognitive processes. Here’s what we learned.

Published
21 June 2017
From
BETA blog
← First12345...15Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.